Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Trial of Sublingual Misoprostol in Addition to Routine Uterotonics to Reduce Primary Postpartum Haemorrhage in Low Risk Women After Vaginal Delivery

NCT05079061 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT05079061
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05079061 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Trial of Sublingual Misoprostol in Addition to Routine Uterotonics to Reduce Primary Postpartum Haemorrhage in Low Risk Women After Vaginal Delivery
Lead sponsor
The University of Hong Kong
Phase
Phase 4
Overall status
Unknown status
Start date
April 30, 2022
Completion date
June 30, 2024
Enrollment
1,300 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

delivery complication, misoprostol, primary postpartum hemorrhage